ClinConnect ClinConnect Logo
Search / Trial NCT06600503

The Effect of a Mobile Application on Enhancing Pulmonary Rehabilitation After Lung Cancer Surgery

Launched by NATIONAL CHENG KUNG UNIVERSITY · Sep 17, 2024

Trial Information

Current as of July 23, 2025

Not yet recruiting

Keywords

Pulmonary Rehabilitation Mobile Application Telerehabilitation Lung Cancer

ClinConnect Summary

This clinical trial is looking at how a mobile app can help patients recover their lung function after having surgery for lung cancer. The main goal is to see if using this app makes a difference in how well patients do in their rehabilitation compared to those who only receive standard care. Participants will be divided into two groups: one group will use the mobile app for exercises and support, while the other group will get traditional health education and an exercise guide. The study will last about 7 weeks, with assessments happening at different points to track progress.

To join the trial, participants must be over 20 years old, have a primary diagnosis of lung cancer, and be scheduled for lung surgery. They should be able to understand the study and give their consent. However, those with certain health issues, previous lung surgeries, or other significant medical conditions may not be eligible. Overall, this trial aims to find out if a mobile app can make recovery after lung surgery easier and more effective for patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • age over 20 years
  • primary diagnosis of lung cancer at any stage and type
  • referral to lung cancer resection by thoracotomy or videothoracoscopy
  • ability to understand and consent to the trial procedures
  • conscious and cognition intact
  • Exclusion Criteria:
  • included adjuvant treatments (chemotherapy or radiotherapy)
  • previous history of thoracic surgery
  • neurological and/or musculoskeletal comorbidities
  • visual or hearing impairment
  • acute respiratory illness

About National Cheng Kung University

National Cheng Kung University (NCKU) is a prestigious research institution located in Tainan, Taiwan, renowned for its commitment to advancing medical science and innovation. With a strong emphasis on interdisciplinary collaboration, NCKU conducts cutting-edge clinical trials aimed at improving healthcare outcomes and addressing critical health challenges. The university leverages its extensive academic resources and state-of-the-art facilities to foster high-quality research and development, ensuring that its clinical trials adhere to rigorous ethical standards and regulatory compliance. NCKU's dedication to education, research, and community service positions it as a leading sponsor in the field of clinical research, contributing significantly to the global medical landscape.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported